Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview

Organogenesis Holdings

04/08/2026 22:15

Organogenesis Holdings Inc. ORGO.OQ ORGO.O is expected to  show a fall in quarterly revenue when it reports  results on August 6 for the period ending June 30 2026
The Canton Massachusetts-based  company is expected to report a 46.3% decrease in revenue to $54.25 million from $101.01 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.The company's guidance on May 7 2026, for the period ended June 30, was for revenue between $48.48 million and $51.51 million.
​LSEG's mean analyst estimate for Organogenesis Holdings Inc. is for a loss of 35 cents per share. 
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Organogenesis Holdings Inc. is $3.00, about 28.2% above its last closing price of $2.34
This summary was machine generated August 4 at 21:15 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)